Title : Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD.

Pub. Date : 2018

PMID : 29773947






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Purpose: This study investigated the efficacy, safety, and pharmacokinetics of the inhaled corticosteroid/long-acting beta2-agonist fixed-dose combination budesonide/formoterol fumarate (BFF) metered dose inhaler (MDI), compared with the monocomponents budesonide (BD) MDI and formoterol fumarate (FF) MDI, in patients with moderate-to-severe COPD. Budesonide potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens